Notably, TAGLN2 expression significantly increased in the paired after-progression tissues compared with before-progression tissue from the same individual, while CRNN expression decreased, suggesting a correlation of TAGLN2 and CRNN with ESCC progression. The gene discussed is TAGLN2; the disease is esophageal squamous cell carcinoma.